معرفی
Prof. Dirk Jan van Veldhuisen is a Professor of Cardiology at the University of Groningen’s Faculty of Medical Sciences and Head of the Department of Cardiology at the University Medical Center Groningen (UMCG). He leads the DECISION trial (funded by the Dutch Heart Foundation) and serves as Principal Investigator in major heart failure studies such as PARADIGM-HF and REDUCE LAP-HF II. His research focuses on heart failure pathophysiology, epicardial adipose tissue dynamics, diuretic therapy optimization, and sex-specific risk factors for cardiovascular diseases.
Key research themes include heart failure subtypes (HFpEF/HFmrEF), genetic variants influencing arrhythmia risk, and translational studies linking nutritional indices to clinical outcomes. He actively contributes to international clinical trials evaluating novel therapies and devices for heart failure management. His work integrates epidemiological studies (e.g., 25-year PREVEND cohort) with mechanistic investigations, emphasizing both basic science and clinical application.
Prof. van Veldhuisen’s academic leadership includes editorial roles in high-impact journals like the European Heart Journal and European Journal of Heart Failure. He maintains a personal research website (http://veldhuisen.comuv.com/) and collaborates globally through initiatives like the ESC Heart Failure Association. His team explores innovative diagnostic tools (e.g., imaging biomarkers) and therapeutic strategies targeting epicardial adipose tissue and diuretic response variability.
